Drug comparisons
Linagliptin vs Tolazamide
Compare linagliptin (Tradjenta) vs tolazamide for type 2 diabetes: efficacy, hypoglycemia risk, weight effects, side effects, and which may suit you better.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when patients on older first-generation sulfonylureas like tolazamide consider switching to a modern DPP-4 inhibitor for better safety.
Bottom line
Linagliptin typically offers a superior safety profile over tolazamide for most adults with type 2 diabetes.
All medication comparisons